Regulatory context
Regulatory context; not efficacy evidence
No matched controlled human trial of this exact complete formulation was verified.
Reported findings. Background context only. Matched evidence for the exact marketed formulation is not established by this reference.
Nonresponse. Nonresponse frequency not established in this excerpt.
Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.
Limits. A commercial blend must be studied as the actual preparation; parent-peptide trials and supplier marketing are not complete-formula efficacy evidence.
Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.
Read original source ↗Editorial review 2026-10-09. Clinician review pending.
Human report
Original LVLUP GHK-Cu customer review
One public customer account in seller-connected collection; clinical outcomes and reporter independence unverified.
Reported findings. Reported gastrointestinal symptoms absent after about two weeks using the attached GHK-Cu product.
Nonresponse. Defined nonresponse endpoint not described.
Harms. Adverse effects not described; systematic assessment and safety are not established.
Limits. Natural recovery and other treatments unresolved; no verified gastritis diagnosis or tissue repair. One seller-connected publicly attributed customer report; not causal proof, independent clinical verification, or a population response/safety rate. Absence of described adverse events is not established tolerability or safety. No other people mentioned by a reporter become independent outcomes. Attached product card supplies product identity; body alone may not name it. Historical formula and current stock equivalence unverified.
Preparation: GHK-Cu. Exact attached commercial product title; formulation revision, batch, ingredients at exposure and equivalence to current catalog unverified. Route: Not explicitly specified in this reporter body; current capsule marketing cannot establish actual route.
Read original source ↗Editorial review 2026-10-10. Clinician review pending.